Like whole blood for transplants, platelets are perpetually in short supply. But these sticky cell fragments come with an added challenge—while whole blood can be kept for as long as 35 days after ...

Researchers have developed synthetic platelets that can be used to stop bleeding and enhance healing at the site of an injury. The researchers have demonstrated that the synthetic platelets work well ...

A freeze-dried blood product that could be stored for years on ambulances or in remote emergency departments is showing promise at treating traumatic brain injuries. The news comes from a mouse study ...

Platelets are small types of blood cells that prevent excessive bleeding. It’s possible to develop low or high platelet counts related to a number of health conditions. Platelets are one of the main ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...

Biomedical engineers report a new application for their synthetic platelets: treating the genetic condition that prevents blood from clotting, Von Willebrand disease (VWD). The most common of all ...

Chemotherapy-induced thrombocytopenia (CIT) is a common side effect of chemotherapy treatment. It occurs when chemotherapy drugs affect platelet production. Platelets are a type of blood cells that ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Essential thrombocythemia (ET) is a type of myeloproliferative neoplasm (MPN), a rare blood disorder that causes an increase in the number of blood cells. Some symptoms include headaches, dizziness, ...

CAMT is a serious and often life threatening genetic disorder. It leads to bleeding problems that are typically present from birth. A timely stem cell transplant is the only cure. Congenital ...